Adverse Event Profile of Blinatumomab in Acute Lymphoblastic Leukemia
3 Ansichten
• 08/04/23
0
0
Einbetten
administrator
Abonnenten
In this segment, Raoul Tibes, MD, PhD, highlights common toxicities to be aware of in patients with acute lymphoblastic leukemia receiving blinatumomab therapy.
Zeig mehr
Facebook Kommentare
SORT BY-
Beste Kommentare
-
Neueste Kommentare